Volume 26, Issue 2 (6-2023)
jha 2023, 26(2): 11-32 |
Back to browse issues page
Ali Mohammad Mosadeghrad1 
, Mahdi Abbasi2 , Amir Rezaei Adriani3 , Mohammadreza Mirzaei Gudarzi4 , Alireza Jafari-Azad 5
, Mahdi Abbasi2 , Amir Rezaei Adriani3 , Mohammadreza Mirzaei Gudarzi4 , Alireza Jafari-Azad 5
1- Professor, School of Public Health, Tehran University of Medical Sciences, Tehran
2- PhD. student, School of Public Health, Tehran University of Medical Sciences, Tehran
3- Pharm.D. student, School of Pharmacy, Tehran University of Medical Sciences, Tehran
4- MD. student, School of Medicine, Tehran University of Medical Sciences, Tehran
5- MD. student, School of Medicine, Tehran University of Medical Sciences, Tehran ,alireza13780803@gmail.com
2- PhD. student, School of Public Health, Tehran University of Medical Sciences, Tehran
3- Pharm.D. student, School of Pharmacy, Tehran University of Medical Sciences, Tehran
4- MD. student, School of Medicine, Tehran University of Medical Sciences, Tehran
5- MD. student, School of Medicine, Tehran University of Medical Sciences, Tehran ,
Abstract: (1071 Views)
Introduction: The communicable disease surveillance system includes the collection, analysis, and interpretation of data related to communicable diseases to be used in planning, implementing, and evaluating public health policies and practices. Iran's communicable disease surveillance system (ICDSS) is facing numerous challenges. This research aimed to identify the strengths, weaknesses, opportunities, and threats of ICDSS and provide solutions to strengthen it.
Methods: The research was conducted using a scoping review method. Articles and documents on ICDSS published between 2000 and 2022 were searched using appropriate keywords in the electronic databases of PubMed, Scopus, Web of Science, Magiran, SID, Google, and Google Scholar search engines. Finally, 41 studies were selected and analyzed using MAXQDA software and the framework analysis method.
Results: Strengths, weaknesses, opportunities, threats, and enhancement strategies to ICDSS were identified and grouped into five themes of the priority diseases targeted for surveillance, the structure of the surveillance system, core functions of the surveillance system, support functions of the surveillance system, and quality of the surveillance system. The most important strengths of ICDSS were the eradication of some infectious diseases, rapid implementation in critical situations, and high efficiency. The low motivation of employees, inefficiency of the reporting system in hospitals, and weak inter-departmental cooperation in prioritizing diseases were among the weaknesses. Using advanced diagnostic equipment and the increase of public awareness about infectious diseases are the main opportunities and population dispersion; the epidemy of infectious diseases in neighboring countries and the presence of immigrants in the country were the main threats to ICDSS. Solutions such as strengthening the infectious disease management center, integrating the CDSS into the family medicine program, integrating different parts of the surveillance system, regularly publishing the results, and creating an effective two-way feedback system were suggested for strengthening ICDSS.
Conclusion: Structures, processes, and core functions of ICDSS should be strengthened. Strategic analysis of ICDSS provides evidence to health policymakers to implement corrective interventions.
Methods: The research was conducted using a scoping review method. Articles and documents on ICDSS published between 2000 and 2022 were searched using appropriate keywords in the electronic databases of PubMed, Scopus, Web of Science, Magiran, SID, Google, and Google Scholar search engines. Finally, 41 studies were selected and analyzed using MAXQDA software and the framework analysis method.
Results: Strengths, weaknesses, opportunities, threats, and enhancement strategies to ICDSS were identified and grouped into five themes of the priority diseases targeted for surveillance, the structure of the surveillance system, core functions of the surveillance system, support functions of the surveillance system, and quality of the surveillance system. The most important strengths of ICDSS were the eradication of some infectious diseases, rapid implementation in critical situations, and high efficiency. The low motivation of employees, inefficiency of the reporting system in hospitals, and weak inter-departmental cooperation in prioritizing diseases were among the weaknesses. Using advanced diagnostic equipment and the increase of public awareness about infectious diseases are the main opportunities and population dispersion; the epidemy of infectious diseases in neighboring countries and the presence of immigrants in the country were the main threats to ICDSS. Solutions such as strengthening the infectious disease management center, integrating the CDSS into the family medicine program, integrating different parts of the surveillance system, regularly publishing the results, and creating an effective two-way feedback system were suggested for strengthening ICDSS.
Conclusion: Structures, processes, and core functions of ICDSS should be strengthened. Strategic analysis of ICDSS provides evidence to health policymakers to implement corrective interventions.
Type of Study: Review |
Subject:
Health Services Management
Received: 2023/04/4 | Accepted: 2023/06/19 | Published: 2023/08/6
Received: 2023/04/4 | Accepted: 2023/06/19 | Published: 2023/08/6
References
1. World Health Organization. Protocol for the assessment of national communicable disease surveillance and response systems: Guidelines for assessment teams. Switzerland: World Health Organization; 2001. 76 p. Report No.: WHO/CDS/CSR/ISR/2001.2.
2. World Health Organization. Communicable disease surveillance and response systems: Guide to monitoring and evaluating. Switzerland: World Health Organization; 2006. 90 p. Report No.: WHO/CDS/EPR/LYO/2006.2.
3. Abbasabadi-Arab M, Khankeh HR, Mosadeghrad AM, Farrokhi M. Developing a hospital disaster risk management evaluation model. Risk Manag Healthc Policy. 2019;12:287-96. [DOI:10.2147/RMHP.S215444]
4. Makwana N. Public health care system's preparedness to combat epidemics after natural disasters. J Family Med Prim Care. 2020;9(10):5107-12. [DOI:10.4103/jfmpc.jfmpc_895_19]
5. Centers for Disease Control and Prevention. Early warning disease surveillance after a flood emergency-Pakistan, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(49):1002-7.
6. Nuzzo JB, Meyer D, Snyder M, Ravi SJ, Lapascu A, Souleles J, et al. What makes health systems resilient against infectious disease outbreaks and natural hazards? Results from a scoping review. BMC Public Health. 2019;19:1-9. [DOI:10.1186/s12889-019-7707-z]
7. World Health Organization. 10 proposals to build a safer world together - strengthening the global architecture for health emergency preparedness, response and resilience. Geneva: WHO; 2022.
8. Flahault A, Blanchon T, Dorleans Y, Toubiana L, Vibert J-F, Valleron A-J. Virtual surveillance of communicable diseases: A 20-year experience in France. Stat Methods Med Res. 2006;15(5):413-21. [DOI:10.1177/0962280206071639]
9. Monterrubio-Flores E, Ramírez-Villalobos MD, Espinosa-Montero J, Hernandez B, Barquera S, Villalobos-Daniel VE, et al. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: Factors associated with increased case-fatality rates. Int J Epidemiol. 2021;50(2):430-45. [DOI:10.1093/ije/dyab008]
10. Jonsson JS, Sigurdsson EL. The power of primary health care. Scand J Prim Health Care. 2020;38(4):361-2. [DOI:10.1080/02813432.2020.1841507]
11. Aborode AT, Hasan MM, Jain S, Okereke M, Adedeji OJ, Karra-Aly A, et al. Impact of poor disease surveillance system on COVID-19 response in Africa: Time to rethink and rebuilt. Clin Epidemiol Glob Health. 2021;12:1-4. [DOI:10.1016/j.cegh.2021.100841]
12. Moradi Gh, Mohamadi-Bolbanabad A, Ghaderi E, Shokri A, Mohammadi T, et al. Atlas of prevalence and incidence of communicbale diseases. Iran: Ministry Of Health and Medical Education; 2021. [In Persian]
13. Ministry Of Health and Medical Education. List of infectious diseases and syndromes under surveillance [slide]. Tehran: Ministry Of Health and Medical Education; 2020. 43 slides: color. [In Persian]
14. HabibiSaravi R, Khankeh H, Azar A, Ghasemihamedani F. Communicable diseases surveillance system in Iran: Strengths and weaknesses 30 years following its implementation. Health in Emergencies and Disasters Quarterly. 2019;5(1):25-36. [In Persian] [DOI:10.32598/hdq.5.1.34.1]
15. Hosseiny M, Moradi G, Janati A, Gouya MM, Ghaderi E. Problems of health care systems and disease reporting for communicable diseases and surveillance in hospitals and the potential solutions: A qualitative study. Scientific Journal of Kurdistan University of Medical Sciences. 2015;20(4):101-11. [In Persian]
16. Mosadeghrad AM. Comments on Iran hospital accreditation system. Iran J Public Health. 2016;45(6):837-9.
17. Neyazi N, Mosadeghrad AM, Afshari M, Isfahani P, Safi N. Strategies to tackle non-communicable diseases in Afghanistan: A scoping review. Front Public Health. 2023;11:1-15. [DOI:10.3389/fpubh.2023.982416]
18. Arksey H, O'Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19-32. [DOI:10.1080/1364557032000119616]
19. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess B, editors. Analyzing qualitative data. London: Routledge; 1994. p. 187-208.
20. Pourghaznein T, Salati S. National approach in response to the COVID-19 pandemic in Iran. Int J Community Based Nurs Midwifery. 2020;8(3):275-6.
21. Mosadeghrad AM. Factors influencing healthcare service quality. Int J Health Policy Manag. 2014;3(2):77-89. [DOI:10.15171/ijhpm.2014.65]
22. Janati A, Hosseiny M, Gouya MM, Moradi Gh, Ghaderi E. Communicable disease reporting systems in the world: A systematic review article. Iran J Public Health. 2015;44(11):1453-65.
23. Karami Jooshin M, Izanloo H, Saghafipour A, Rezaei F, Asadi Ghalhari M. A survey of probable risk factors for cholera outbreak in Qom, central Iran, in 2017. Iranian Journal of Epidemiology. 2019;14(4):404-9. [In Persian]
24. Moradi Gh, Asadi H, Gouya MM, Nabavi M, Norouzinejad A, Mohamadi-Bolbanabad A. Recommendations for improving communicable diseases surveillance system in Iran from the viewpoint of stakeholders: A qualitative study. Journal of Mazandaran University of Medical Sciences. 2019;29(174):172-8. [In Persian]
25. Moradi Gh, Asadi H, Gouya MM, Nabavi M, Norouzinejad A, Karimi M, et al. The communicable diseases surveillance system in Iran: Challenges and opportunities. Arch Iran Med. 2019;22(7):361-8.
26. HabibiSaravi R, Seyedin H, Mosadeghrad AM, Gouya MM. Communicable diseases management in disasters: An analysis of improvement measures since 2005, Islamic Republic of Iran. East Mediterr Health J. 2019;25(4):269-81. [DOI:10.26719/emhj.18.037]
27. Khoshdel A, Noori Fard M, Pezeshkan R, Salahi-Moghaddam A. Mapping the important communicable diseases of Iran. Health and Development Journal. 2012;1(1):31-46. [In Persian]
28. Bagherian H, Farahbakhsh M, Rabiei R, Moghaddasi H, Asadi F. National communicable disease surveillance system: A review on information and organizational structures in developed countries. Acta Inform Med. 2017;25(4):271-6. [DOI:10.5455/aim.2017.25.271-276]
29. Hosseiny M, Moradi Gh, Gouya MM, Janati A, Ghaderi E. Designing a rapid assessment questionnaire to evaluate the communicable diseases surveillance system for hospitals: An applied study. Iranian Journal of Epidemiology. 2017;13(1):30-40. [In Persian]
30. Macinko J, Starfield B, Shi L. Quantifying the health benefits of primary care physician supply in the United States. Int J Health Serv. 2007;37(1):111-26. [DOI:10.2190/3431-G6T7-37M8-P224]
31. Chu-Chun T, Che-Ming Y. Is over-reporting a problem in mandatory communicable disease reporting? The taiwanese experience on Enterovirus 71. J Infect Dev Ctries. 2014;8(10):1294-300. [DOI:10.3855/jidc.4623]
32. Degeling C, Johnson J, Gilbert GL. Perspectives of Australian policy-makers on the potential benefits and risks of technologically enhanced communicable disease surveillance-a modified Delphi survey. Health Res Policy Syst. 2019;17(1):1-11. [DOI:10.1186/s12961-019-0440-3]
33. Hanafusa S, Muhadir A, Santoso H, Tanaka K, Anwar M, Sulistyo ET, et al. A surveillance model for human avian influenza with a comprehensive surveillance system for local-priority communicable diseases in south Sulawesi, Indonesia. Trop Med Health. 2012;40(4):141-7. [DOI:10.2149/tmh.2012-10]
34. Sahal N, Reintjes R, Eltayeb EM, Aro AR. Feasibility of implementing recommendations to improve communicable diseases surveillance-a modified Delphi study. Afr Health Sci. 2011;11(Supp 1):S93-9. [DOI:10.4314/ahs.v11i3.70077]
35. Valenciano M, Luquero FJ, Moren A. Communicable disease surveillance during complex emergencies. In: M'ikanatha NM, Lynfield R, Van Beneden CA, de Valk H, editors. Infectious Disease Surveillance. 2nd ed. Hoboken: John Wiley & Sons; 2013. p. 361-75. [DOI:10.1002/9781118543504.ch29]
36. Ghiasipour M, Mosadeghrad AM, Arab M, Jaafaripooyan E. Leadership challenges in health care organizations: The case of Iranian hospitals. Med J Islam Repub Iran. 2017;31:1-8. [DOI:10.14196/mjiri.31.96]
37. Azar F, Masoori N, Meidani Z, Paul L. Proposal for a modernized Iranian notifiable infectious diseases surveillance system: Comparison with USA and Australia. East Mediterr Health J. 2010;16(7):771-7. [DOI:10.26719/2010.16.7.771]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |